• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families.

作者信息

Azzouzi Abdel-Rahene, Stoppa-Lyonnet Dominique, Roupret Morgan, Larre Stéphane, Mangin Philippe, Cussenot Oliver

机构信息

Service d'Urologie, CHU d'Angers, Angers, France.

出版信息

Int J Urol. 2007 May;14(5):445-6. doi: 10.1111/j.1442-2042.2006.01712.x.

DOI:10.1111/j.1442-2042.2006.01712.x
PMID:17511731
Abstract

It is known that in some families an association exists between breast and prostate cancer. Several reports have suggested that BRCA2 mutations may be associated with an increased risk of these cancers. Herein, we report three cases of early onset of prostate cancer in families with female and male breast cancers. In each case, the familial phenotype is associated with a mutation of the BRCA2 gene. More generally, genetic counseling, including screening for BRCA2 mutations, should become standard practice in kindred with prostate and breast cancers.

摘要

相似文献

1
BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families.
Int J Urol. 2007 May;14(5):445-6. doi: 10.1111/j.1442-2042.2006.01712.x.
2
BRCA2 mutation in a family with hereditary prostate cancer.一个遗传性前列腺癌家族中的BRCA2基因突变
Genes Chromosomes Cancer. 2001 Mar;30(3):299-301.
3
Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes.高危乳腺癌/卵巢癌家族中BRCA2重排的筛查:奠基者效应的证据及相关表型分析
J Clin Oncol. 2007 May 20;25(15):2027-34. doi: 10.1200/JCO.2006.06.9443.
4
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.BRCA2基因家族中的癌症风险:对乳腺和卵巢以外部位的估计
J Med Genet. 2005 Sep;42(9):711-9. doi: 10.1136/jmg.2004.028829.
5
Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families.BRCA1/2基因突变的概率随卵巢组织学类型而异:442个卵巢癌家族筛查结果
Clin Genet. 2008 Apr;73(4):338-45. doi: 10.1111/j.1399-0004.2008.00974.x. Epub 2008 Feb 26.
6
A recurrent mutation in PALB2 in Finnish cancer families.芬兰癌症家族中PALB2基因的复发性突变。
Nature. 2007 Mar 15;446(7133):316-9. doi: 10.1038/nature05609. Epub 2007 Feb 7.
7
Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.多个乳腺癌家系中 BRCA2 突变男性前列腺癌特异性生存降低。
Cancer Prev Res (Phila). 2011 Jul;4(7):1002-10. doi: 10.1158/1940-6207.CAPR-10-0397.
8
Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer.对389个患有乳腺癌和前列腺癌的冰岛家系进行分离分析。
Genet Epidemiol. 2002 Nov;23(4):349-63. doi: 10.1002/gepi.10188.
9
Breast cancer as a second primary in patients with prostate cancer--estrogen treatment or association with family history of cancer?前列腺癌患者发生的第二原发性乳腺癌——雌激素治疗还是与癌症家族史有关?
J Urol. 2006 Aug;176(2):538-43. doi: 10.1016/j.juro.2006.03.036.
10
[Analysis of BRCA2 gene mutations among familial and/or early-onset breast cancer patients in eastern Shandong of China].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Apr;25(2):195-8.

引用本文的文献

1
Analysis of the Clinical Advancements for -Related Malignancies Highlights the Lack of Treatment Evidence for -Positive Male Breast Cancer.对 - 相关恶性肿瘤临床进展的分析凸显了 - 阳性男性乳腺癌治疗证据的匮乏。 (注:原文中存在两个未明确的“-”,可能会影响完整准确理解,需根据实际完整内容进一步完善。)
Cancers (Basel). 2022 Jun 28;14(13):3175. doi: 10.3390/cancers14133175.